Purchase Order 12805B24P0192
- Not listed
- Sartorius Stedim North America Inc. was awarded a $326,622.90 firm fixed-price purchase order by the U.S. Department of Agriculture's Agricultural Research Services to supply and install a Biostat B bioreactor dual control unit at the National Center for Agricultural Utilization Research (NCAUR) in Bohemia, New York. The contract, awarded on September 6, 2024, with completion by January 4, 2025, fulfills the government's requirement for a dual control unit compatible with existing B. Braun...
- This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft. The $198,816.00 fixed-price contract is for maintenance on a Sartorius Biostat B-DCU II parallel bioreactor system. The contract has no set-aside designation and was awarded on December 20, 2018, with a completion date of January 1, 2022. Sartorius Stedim North America Inc. has...
- This federal contract award to Sartorius Stedim North America Inc. is for the procurement of two AMBR 250 high throughput bioreactor systems for the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Production Program (VPP). The $4,507,574 firm fixed price purchase order requires delivery within 65 days. The bioreactor systems must meet specific technical requirements to support NIAID's mammalian cell culture research and development. This contract is not set aside for any...
- This is a $17,904.60 firm fixed-price purchase order awarded by a civilian federal agency to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The award is for a BIOSTAT A UNIVESSEL (BIOREACTOR 1L) reference quotation #1411-MHH-5980. This contract was not set aside and does not appear to be associated with a larger contract vehicle. Sartorius Stedim North America Inc. is a leading provider of advanced laboratory equipment, consumables, and...
- The Department of Agriculture Agricultural Research Service Plains Area awarded a $3.2 million firm fixed price purchase order to 1st American Medical Distributors, Inc. to deliver a Sartorius BDM FFO bioreactor and ABMR 250 modular system. The solicitation sought seven bioreactor/fermentor systems with capacities ranging from 1 liter to 200 liters to support multiple cell culture processes at the USDA Agricultural Research Service Plains Area National Bio and Agro-Defense Facility in Manhattan,...
- <p>The National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Sartorius Stedim North America Inc. for an AMBIS 1968057 Biostat B-DCU 2-fold bioreactor fermenter system (120V) on August 8, 2019, valued at $205,503.40. Work is performed in Bohemia, New York. The order carries no set-aside designation. Ultimate completion date is December 6, 2019. The solicitation was posted July 19, 2019, with a due date of July 29, 2019.</p>
- This is a $210,267.91 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The contract is for the delivery of off-line gas analyzers, on-line and integral nutrient analyzers, bioreactor probes, and accessories for a Sartorius BIOSTAT bioreactor system. This award does not have a set-aside designation. Sartorius Stedim North America...
- The Department of the Army Medical Command awarded a $118,940.00 firm fixed price purchase order to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft. The contract is for the supply of a VIRUS COUNTER 3100, with a completion date of September 25, 2020. This award was made on a competitive basis with no set-aside designation. Sartorius Stedim North America Inc. has fulfilled over $2 million in federal contracts since 2019, providing laboratory...
- This firm fixed-price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the U.S. Department of Health and Human Services, to Sartorius Stedim North America Inc., a foreign-owned, for-profit organization specializing in advanced laboratory equipment and services. The $77,605.00 contract, awarded on September 27, 2010, is for the delivery of a BDCU 11 TWIN system by the ultimate completion date of March 30, 2011. The...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order for $144,920.00 to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft, to provide an AMBR core system with 8-channel crossflow for COVID-19 research and vaccine development. This equipment will be used at the Vaccine Production Program Laboratory to enable parallel tangential...
Sartorius Stedim North America Inc. has been awarded a firm fixed-price purchase order valued at $182,615.50 for the installation and training of large-scale bioreactors. The contract, awarded on August 1, 2024, supports the biodefense medical (BDM) initiative's requirement for large-scale bioreactor systems essential for efficiently producing biologics at commercial scale. Performance will be completed in Manhattan, Kansas, with a deadline of September 30, 2025. This is a civilian contract funded through the Plains Area agency with no small business set-aside designation. As a leading provider of bioprocessing equipment and a registered federal contractor since 2008, Sartorius Stedim North America Inc. brings substantial expertise in biopharmaceutical manufacturing technologies. The company, a division of German multinational Sartorius Aktiengesellschaft, has secured over $9 million in federal contract awards since 2021 and regularly supplies specialized laboratory equipment and bioreactor systems to agencies including the National Institutes of Health and Food and Drug Administration. This award reflects the company's established role as a specialized supplier of original equipment manufacturer services and demonstrates continued federal investment in domestic biodefense production capabilities through advanced bioreactor infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($33k) | 2/9/26 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 7/29/25 | |
| Not listed | Not listed | $215.3k | 7/31/24 |